As of 2025-03-19, the Relative Valuation of Bright Minds Biosciences Inc (DRUG.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 51.59 CAD, the upside of Bright Minds Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-03-17 | -340.05 |
| 2025-03-13 | -340.84 |
| 2025-03-12 | -342.55 |
| 2025-03-11 | -329.17 |
| 2025-03-10 | -306.83 |
| 2025-03-07 | -346.04 |
| 2025-03-06 | -336.16 |
| 2025-03-05 | -342.68 |
| 2025-03-04 | -305.31 |
| 2025-02-28 | -342.62 |
| 2025-02-26 | -315.20 |
| 2025-02-25 | -320.21 |
| 2025-02-24 | -337.61 |
| 2025-02-21 | -337.21 |
| 2025-02-20 | -336.36 |
| 2025-02-19 | -352.24 |
| 2025-02-18 | -355.54 |
| 2025-02-14 | -398.84 |
| 2025-02-13 | -440.04 |
| 2025-02-12 | -429.82 |
| 2025-02-11 | -428.70 |
| 2025-02-10 | -436.81 |
| 2025-02-07 | -408.33 |
| 2025-02-06 | -381.84 |
| 2025-02-05 | -361.73 |
| 2025-02-04 | -344.73 |
| 2025-02-03 | -358.70 |
| 2025-01-31 | -313.68 |
| 2025-01-30 | -294.04 |
| 2025-01-29 | -288.70 |
| 2025-01-28 | -288.30 |
| 2025-01-27 | -297.99 |
| 2025-01-24 | -306.30 |
| 2025-01-23 | -304.19 |
| 2025-01-22 | -306.89 |
| 2025-01-21 | -340.71 |
| 2025-01-20 | -355.93 |
| 2025-01-16 | -356.66 |
| 2025-01-15 | -351.52 |
| 2025-01-10 | -369.11 |
| 2025-01-08 | -381.51 |
| 2025-01-07 | -385.99 |
| 2025-01-06 | -384.34 |
| 2025-01-03 | -373.27 |
| 2025-01-02 | -402.07 |
| 2024-12-31 | -340.11 |
| 2024-12-30 | -350.92 |
| 2024-12-27 | -378.61 |
| 2024-12-24 | -356.85 |
| 2024-12-23 | -365.88 |